Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib

Patrick Harrington, Katie J. Doores, Jamie Saunders, Marc de Lord, Chandan Saha, Thomas Lechmere, Hataf Khan, Ho Pui Jeff Lam, Amy O’ Reilly, Claire Woodley, Susan Asirvatham, Richard Dillon, Natalia Curto-Garcia, Jennifer O’ Sullivan, Shahram Kordasti, Kavita Raj, Michael H. Malim, Deepti Radia, Donal McLornan, Claire HarrisonHugues de Lavallade*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

6 Citations (Scopus)
Original languageEnglish
Article number73
JournalBlood Cancer Journal
Volume12
Issue number4
Early online date22 Apr 2022
DOIs
Publication statusE-pub ahead of print - 22 Apr 2022

Cite this